相关实验视频
Updated: May 3, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
2型糖尿病治疗相关属性的不实用性:系统性审查
Shitong Xie1,2, Xinran Liu1,2, Meixuan Li3
1School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
概括
这一系统性审查综合了患者对2型糖尿病 (T2DM) 治疗的偏好. 体重变化和剂量频率显著影响治疗效果,影响患者的选择.
科学领域:
- 卫生经济学 卫生经济学
- 患者报告的结果
- 糖尿病管理 糖尿病管理
背景情况:
- 2型糖尿病 (T2DM) 治疗涉及各种影响患者生活质量的属性.
- 量化患者对这些属性的偏好对于明智的治疗决策和医疗保健政策至关重要.
研究的目的:
- 系统地审查和综合关于与2型糖尿病治疗相关属性的不实用性相关的文献.
- 识别通常评估的属性及其相关的无效值.
主要方法:
- 在多个数据库 (Medline,Embase,Cochrane Library,PsycINFO,EconLit,CINAHL) 进行了全面的文献搜索,截至2024年12月.
- 系统性审查遵循PRISMA指南,使用NICE和ROBINS-I检查清单评估偏差的质量和风险.
- 诱导方法包括时间权衡和标准博.
主要成果:
- 包括9项研究,59-4060名参与者,主要来自英国,专注于T2DM患者和公众.
- 确定了八种治疗属性,最常见的是体重变化和剂量频率.
- 不实用性值各不相同;对于重量变化,值在 -0.106 到 0.047.7 之间. 偏好更喜欢每周服用,而不是每天服用,每天服用一次,而不是每天服用多次.
结论:
- 对于T2DM治疗属性的已发表的不实用性对患者偏好有重大影响.
- 体重变化和剂量频率成为报告中最大的不实用性的关键属性.
- 跨研究的异质性需要在解释结果时仔细考虑提取方法,种群和地理背景.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17

